ReP USP - Resultado da busca

Artigo de periodico
Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin (2009)
Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Clinica Lipidology. Unidade: FCF
Subjects: DOENÇAS CARDIOVASCULARES, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo e HIRATA, Mario Hiroyuki. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, v. 4, n. 4, p. 419-423, 2009Tradução . . Disponível em: https://doi.org/10.2217/clp.09.32. Acesso em: 02 out. 2024.
APA
Hirata, R. D. C., & Hirata, M. H. (2009). Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, 4( 4), 419-423. doi:10.2217/clp.09.32
NLM
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 out. 02 ] Available from: https://doi.org/10.2217/clp.09.32
Vancouver
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 out. 02 ] Available from: https://doi.org/10.2217/clp.09.32
Artigo de periodico
Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays (2009)
Lima Neto, Lidio Gonçalves; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati; Silbiger, Vivian Nogueira; Pastorelli, Carla Prisinzano; Sampaio, Marcelo Ferraz; Armaganijan, Dikran; Rezende, Adriana Augusto de; Doi, Sonia de Quateli; Hirata, Mario Hiroyuki
Source: Genetic Testing and Molecular Biomarkers. Unidade: FCF
Subjects: POLIMORFISMO, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA NETO, Lidio Gonçalves et al. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, v. 13, n. 3, p. 343-347, 2009Tradução . . Disponível em: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147. Acesso em: 02 out. 2024.
APA
Lima Neto, L. G., Hirata, R. D. C., Luchessi, A. D., Silbiger, V. N., Pastorelli, C. P., Sampaio, M. F., et al. (2009). Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, 13( 3), 343-347. Recuperado de http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
NLM
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 out. 02 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
Vancouver
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 out. 02 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
Artigo de periodico
Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells (2009)
Rodrigues, Alice Cristina ; Curi, Rui; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, v. 37, n. 3-4, p. 486-491, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2009.04.006. Acesso em: 02 out. 2024.
APA
Rodrigues, A. C., Curi, R., Hirata, M. H., & Hirata, R. D. C. (2009). Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, 37( 3-4), 486-491. doi:10.1016/j.ejps.2009.04.006
NLM
Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
Vancouver
Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 out. 02 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em